Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Chinese Journal of Cancer Research
Published in: Chinese Journal of Cancer Research 3/2012

01-03-2012 | Original Article

Diphtheria toxin/human B-Cell activating factor fusion protein kills human acute lymphoblastic leukemia BALL-1 cells: An experimental study

Authors: Xin-pu Gao, Zheng-min Liu, Yu-lian Jiao, Bin Cui, Yue-ting Zhu, Jie Zhang, Lai-cheng Wang, Yue-ran Zhao

Published in: Chinese Journal of Cancer Research | Issue 3/2012

Login to get access
Metadata
Title
Diphtheria toxin/human B-Cell activating factor fusion protein kills human acute lymphoblastic leukemia BALL-1 cells: An experimental study
Authors
Xin-pu Gao
Zheng-min Liu
Yu-lian Jiao
Bin Cui
Yue-ting Zhu
Jie Zhang
Lai-cheng Wang
Yue-ran Zhao
Publication date
01-03-2012
Publisher
Chinese Anti-Cancer Association
Published in
Chinese Journal of Cancer Research / Issue 3/2012
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI
https://doi.org/10.1007/s11670-012-0238-0

Other articles of this Issue 3/2012

Chinese Journal of Cancer Research 3/2012 Go to the issue

Original Article

Hepatocellular carcinoma with blood supply from parasitized omental artery: Angiographic appearance and chemoembolization

Original Article

XPC polymorphism increases risk of digestive system cancers: Current evidence from a meta-analysis

Original Article

Individualized chemotherapy in advanced NSCLC patients based on mRNA levels of BRCA1 and RRM1

Original Article

Dys-psychological stress effect on expressions of P53 and NFκBp65 in human ovarian carcinoma In Vivo

Original Article

Reduction of CAII expression in gastric cancer: Correlation with invasion and metastasis

Original Article

Inhibitory effects of 5-Aza-2′-deoxycytidine and trichostatin A in combination with p53-expressing adenovirus on human laryngocarcinoma cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits